Tyra Biosciences Inc TYRA
News
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm
Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)
Tyra Biosciences Gets Rare Pediatric Disease Designation For Achondroplasia Therapy